Authors
Wood is a urologic oncology fellow at Glickman Urological & Kidney Institute at the Cleveland Clinic in Ohio.
Rachelle Manookian, MS, LCGC, is a board-certified genetic counselor specializing in cancer genetics. She has an MS in genetic counseling from the Icahn School of Medicine at Mount Sinai, and a BS in biological sciences with a focus in neurobiology from University of California Irvine, as well as minors in Spanish literature and cognitive psychology.
Chung is a resident at NewYork-Presbyterian/Columbia University Irving Medical Center, New York, New York.
Benidir is a urologic oncology fellow at Cleveland Clinic Glickman Urological and Kidney Institute in Ohio.
Advertisement
Advertisement
Trending on Urology Times
1
LIB-01 enters phase 2b development for erectile dysfunction
2
Treatment Targets, Formulations, and the Future of Testosterone
3
Jonathan Rosenberg, MD, reacts to FDA approval of durvalumab plus EV for MIBC
4
Pearls & Perspectives: Exploring Radiofrequency Therapy for Erectile Dysfunction, With Mohit Khera, MD
5
